Home NuPathe shares soar on news of competing bid
 

Keywords :   


NuPathe shares soar on news of competing bid

2014-01-09 02:36:00| Biotech - Topix.net

NuPathe said in a Securities and Exchange Commission filing that Israel's Teva Pharmaceutical Industries Ltd. wants to buy the company for $3.65 in cash for each NuPathe share, plus up to $3.15 per share in payments if NuPathe's migraine treatment patch Zecuity reaches certain sales milestones.

Tags: news bid shares competing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
08.10Hurricane Milton Potential Storm Surge Flooding Map
08.10Hurricane Milton Probabilistic Storm Surge Graphics
08.10Hurricane Milton Graphics
08.10Hurricane Milton Forecast Discussion Number 12
08.10Hurricane Milton Storm Surge Watch/Warning Map
08.10Hurricane Milton Wind Speed Probabilities Number 12
08.10Hurricane Milton Forecast Advisory Number 12
08.10Hurricane Milton Public Advisory Number 12
More »